Literature DB >> 31506152

[Correlation between serum microRNA-122 and insulin resistance in obese children].

Qiong Chen1, Yao-Dong Zhang, Sheng-Nan Wu, Yong-Xing Chen, Xiao-Jing Liu, Hai-Yan Wei.   

Abstract

OBJECTIVE: To study the relationship between serum microRNA-122 (miR-122) and insulin resistance in obese children.
METHODS: Forty-seven children with severely obesity aged 7-14 years and 45 age- and gender matched healthy children with normal weight (control group) were enrolled. The levels of height, weight, waistline, hip circumference, fasting blood glucose (FBG), fasting insulin (FINS), triglyceride (TG), total cholesterol (TC), free fatty acid (FFA), interleukin-6 (IL-6) and miR-122 in the two groups were measured. Body mass index (BMI), waist-hip ratio (WHR) and insulin resistance index (HOMA-IR) were calculated.
RESULTS: Compared with the control group, the height, weight, BMI, WHR, FINS, HOMA-IR, TG, FFA, IL-6, and miR-122 levels in the obese group were significantly increased (P<0.05). MiR-122 levels in the obese group were positively correlated with FINS, HOMA-IR and IL-6 levels (r=0.408, 0.442, and 0.464 respectively, P<0.05). The changes of miR-122 have a linear regression relationship with IL-6 (b'=0.318, P<0.05).
CONCLUSIONS: The elevated serum miR-122 levels may be correlated with insulin resistance in obese children. The mechanism needs to be further studied.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31506152      PMCID: PMC7390255     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  11 in total

1.  Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study.

Authors:  Joyce M Lee; Megumi J Okumura; Matthew M Davis; William H Herman; James G Gurney
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

2.  Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells.

Authors:  Li Dong; Xiaoyu Hou; Fengsui Liu; Hong Tao; Yunjia Zhang; Hang Zhao; Guangyao Song
Journal:  Cell Biol Int       Date:  2019-04-25       Impact factor: 3.612

3.  MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism.

Authors:  Dimitrios Iliopoulos; Konstantinos Drosatos; Yaeko Hiyama; Ira J Goldberg; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

4.  MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.

Authors:  Guo-Yi Wu; Chen Rui; Ji-Qiao Chen; Eiketsu Sho; Shan-Shan Zhan; Xian-Wen Yuan; Yi-Tao Ding
Journal:  Cell Physiol Biochem       Date:  2017-12-06

5.  Prevalence of overweight/obesity in Chinese children.

Authors:  Jian-Meng Liu; Rongwei Ye; Song Li; Aiguo Ren; Zhiwen Li; Yinghui Liu; Zhu Li
Journal:  Arch Med Res       Date:  2007-08-20       Impact factor: 2.235

6.  Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance.

Authors:  Mathias Röhl; Manolis Pasparakis; Stephanie Baudler; Julia Baumgartl; Dinesh Gautam; Marion Huth; Rossana De Lorenzi; Wilhelm Krone; Klaus Rajewsky; Jens C Brüning
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  Targeting the circulating microRNA signature of obesity.

Authors:  Francisco José Ortega; Josep María Mercader; Victoria Catalán; José María Moreno-Navarrete; Neus Pueyo; Mónica Sabater; Javier Gómez-Ambrosi; Roger Anglada; José Antonio Fernández-Formoso; Wifredo Ricart; Gema Frühbeck; José Manuel Fernández-Real
Journal:  Clin Chem       Date:  2013-02-08       Impact factor: 8.327

8.  Extracellular RNAs Are Associated With Insulin Resistance and Metabolic Phenotypes.

Authors:  Ravi Shah; Venkatesh Murthy; Michael Pacold; Kirsty Danielson; Kahraman Tanriverdi; Martin G Larson; Kristina Hanspers; Alexander Pico; Eric Mick; Jared Reis; Sarah de Ferranti; Elizaveta Freinkman; Daniel Levy; Udo Hoffmann; Stavroula Osganian; Saumya Das; Jane E Freedman
Journal:  Diabetes Care       Date:  2017-02-09       Impact factor: 19.112

9.  Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

Authors:  Peter Willeit; Philipp Skroblin; Alexander R Moschen; Xiaoke Yin; Dorothee Kaudewitz; Anna Zampetaki; Temo Barwari; Meredith Whitehead; Cristina M Ramírez; Leigh Goedeke; Noemi Rotllan; Enzo Bonora; Alun D Hughes; Peter Santer; Carlos Fernández-Hernando; Herbert Tilg; Johann Willeit; Stefan Kiechl; Manuel Mayr
Journal:  Diabetes       Date:  2016-11-29       Impact factor: 9.461

10.  MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells.

Authors:  Masato Nakamura; Tatsuo Kanda; Reina Sasaki; Yuki Haga; Xia Jiang; Shuang Wu; Shingo Nakamoto; Osamu Yokosuka
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more
  2 in total

1.  Relationship of miRNA‑126 and miRNA‑122 expression with type 2 diabetes mellitus and related glucose metabolism parameters: A systematic review and meta‑analysis.

Authors:  Yaling He; Yuqian Li; Zhihan Zhai; Pengling Liu; Luting Nie; Yiquan Zheng; Jian Hou; Wenqian Huo; Zhenxing Mao; Zhenzhong Zhang; Chongjian Wang; Xiaotian Liu
Journal:  Exp Ther Med       Date:  2022-09-05       Impact factor: 2.751

2.  Overexpression of MicroRNA-122 Resists Oxidative Stress-Induced Human Umbilical Vascular Endothelial Cell Injury by Inhibition of p53.

Authors:  Hua-Qing Li; Zhi-Yu Pan; Zhen Yang; Don-Bing Zhang; Qian Chen
Journal:  Biomed Res Int       Date:  2020-10-27       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.